Become A Featured Company

Intrinsic Capital Partners Raises More Than $100 Million

Ryan Allway

November 12th, 2020

News, Top News

CONSHOHOCKEN, Pa., Nov. 10, 2020 /PRNewswire/ — Intrinsic Capital Partners (“Intrinsic”) announced the closing of Intrinsic Health Partners, L.P. (the “Fund”), a $102 million growth equity fund that invests in life science and technology businesses focused on the legal cannabis and hemp industries.

“We are excited to invest on behalf of our investors in this high growth industry,” said Howard Goodwin M.D., one of three founders of Intrinsic. “We believe this is a multi-decade secular trend, and a rare opportunity to invest in a space where there’s tremendous underlying demand, a strong industry-wide growth profile and scarcity of capital,” added Dr. Goodwin.

Founded by principals Gerald Stahlecker, Cornelius Merlini and Goodwin, Intrinsic is the first investment firm to focus on ancillary cannabis and hemp businesses with a team of both experienced institutional investors and life science and technology operators.

Key to Intrinsic’s strategy is its deep network of operating advisors who bring decades of experience in healthcare, technology, consumer marketing and regulatory affairs. The advisors have engaged in supporting Intrinsic’s investment and segment diligence, regulatory evaluations and market risk assessments. They are also actively engaged in building and scaling Intrinsic’s portfolio companies, either as board directors or members of management.

“While developing our investment thesis and fund strategy, it became clear to us that many of these businesses would benefit from more than just capital,” said Merlini. “So, we built a top team of advisors who have scaled valuable businesses and are able to provide our portfolio companies with strategic advice, mentoring, operational support and regulatory know-how,” Merlini added.

Intrinsic’s operator-centric investment model leverages a network of highly accomplished veterans of the consumer, life sciences and technology industries. This advisory group includes:

  • Bill McComb, formerly CEO of Liz Claiborne, Inc., Company Group Chairman for DePuy Orthopedics within Johnson & Johnson, and President of McNeil Consumer Healthcare;
  • Minnie Baylor-Henry, formerly Director, DDMAC, of the FDA, National Health Fraud Coordinator of the FDA, Worldwide VP of Regulatory Affairs for Medical Devices & Diagnostics within Johnson & Johnson, and VP of Medical & Regulatory Affairs for McNeil Consumer Healthcare;
  • Bob Sheroff, formerly Global Head of Supply Chain across multiple divisions within Johnson & Johnson, including Global Biologics at Jansen, and World-Wide VP of Quality at Warner Lambert; and
  • Bob Miller, Ph.D., formerly SVP of Gilead Sciences, Inc. and Head of Quality across multiple divisions of Johnson & Johnson.

While the majority of capital invested in the industry has been focused on state licensed cultivators, dispensaries and recreational brands, Intrinsic specifically focuses on investing in ancillary life science and technology companies that support the broader cannabis and hemp industries.

“This is a unique and opportune time for a fund with dry powder to invest in market segments where traditional capital providers and strategic corporations have largely stayed on the sideline, creating pricing dislocation, attractive private market valuations and ample exit strategies” explained Stahlecker.

To date, Intrinsic has committed $65 million to four portfolio company investments, including ACT Laboratories, Inc. (lab testing), Treez, Inc. (business management software), Hound Labs, Inc. (marijuana and alcohol breathalyzer technology) and Elemental Brands, Inc. (hemp-derived consumer healthcare products). The Intrinsic team expects to invest in two or three more companies with this first fund.

About:

Intrinsic Capital Partners

Intrinsic Capital Partners is a Pennsylvania-based investment firm focused on life science and technology businesses within the legal cannabis and hemp industries. The Intrinsic team brings institutional investment discipline and world-class operating experience to build and scale industry-leading companies that address unmet needs across the supply chain.

Intrinsic Capital Partners employs an operator-centric investment model to create a diverse portfolio of leading companies within the federally legal and emerging cannabis and hemp industries.

SOURCE Intrinsic Capital Partners

This article was published by CFN Enterprises Inc. (OTCQB: CNFN), owner and operator of CFN Media, the industry’s leading agency and digital financial media network dedicated to the burgeoning CBD and legal cannabis industries. Call +1 (833) 420-CNFN for more information.

About Ryan Allway

Mr. Allway has over a decade of experience in the financial markets as both a private investor and financial journalist. He has been actively involved in the cannabis industry since its inception, covering public and private companies.

Network Partners

Follow Us on Social Media

LinkedIn

About CFN Media Group

CFN Enterprises Inc. (OTCQB: CNFN) owns and operates CFN Media Group, the premier agency and financial media network reaching executives, entrepreneurs and consumers worldwide. Through its proprietary content creation, video library, and distribution via www.CannabisFN.com, CFN has built an extensive database of cannabis interest, assisting many of the world’s largest cannabis firms and CBD brands to build awareness and thrive. For more information, please visit www.cfnenterprisesinc.com.

Disclaimer: Matters discussed on this website contain forward-looking statements that are subject to certain risks and uncertainties that could cause actual results to differ materially from any future results, performance or achievements expressed or implied by such statements. CFN Media Group, which owns CannabisFN, is not registered with any financial or securities regulatory authority and does not provide nor claims to provide investment advice or recommendations to readers of this release. CFN Media Group, which owns CannabisFN, may from time-to-time have a position in the securities mentioned herein and will increase or decrease such positions without notice. The Information contains forward-looking statements, i.e. statements or discussions that constitute predictions, expectations, beliefs, plans, estimates, or projections as indicated by such words as "expects", "will", "anticipates", and "estimates"; therefore, you should proceed with extreme caution in relying upon such statements and conduct a full investigation of the Information and the Profiled Issuer as well as any such forward-looking statements. Any forward looking statements we make in the Information are limited to the time period in which they are made, and we do not undertake to update forward looking statements that may change at any time; The Information is presented only as a brief "snapshot" of the Profiled Issuer and should only be used, at most, and if at all, as a starting point for you to conduct a thorough investigation of the Profiled Issuer and its securities and to consult your financial, legal or other adviser(s) and avail yourself of the filings and information that may be accessed at www.sec.gov, www.pinksheets.com, www.otcmarkets.com or other electronic sources, including: (a) reviewing SEC periodic reports (Forms 10-Q and 10-K), reports of material events (Form 8-K), insider reports (Forms 3, 4, 5 and Schedule 13D); (b) reviewing Information and Disclosure Statements and unaudited financial reports filed with the Pink Sheets or www.otcmarkets.com; (c) obtaining and reviewing publicly available information contained in commonlyknown search engines such as Google; and (d) consulting investment guides at www.sec.gov and www.finra.com. You should always be cognizant that the Profiled Issuers may not be current in their reporting obligations with the SEC and OTCMarkets and/or have negative signs at www.otcmarkets.com (See section below titled "Risks Related to the Profiled Issuers, which provides additional information pertaining thereto). For making specific investment decisions, readers should seek their own advice and that of their own professional advisers. CFN Media Group, which owns CannabisFN, may be compensated for its Services in the form of cash-based and/or equity-based compensation in the companies it writes about, or a combination of the two. For full disclosure, please visit: https://www.cannabisfn.com/legal-disclaimer/. A short time after we acquire the securities of the foregoing company, we may publish the (favorable) information about the issuer referenced above advising others, including you, to purchase; and while doing so, we may sell the securities we acquired. In addition, a third-party shareholder compensating us may sell his or her shares of the issuer while we are publishing favorable information about the issuer. Except for the historical information presented herein, matters discussed in this article contain forward-looking statements that are subject to certain risks and uncertainties that could cause actual results to differ materially from any future results, performance or achievements expressed or implied by such statements. CFN Media Group, which owns CannabisFN, is not registered with any financial or securities regulatory authority, and does not provide nor claims to provide investment advice or recommendations to readers of this release. CFN Media Group, which owns CannabisFN, may from time to time have a position in the securities mentioned herein and will increase or decrease such positions without notice. For making specific investment decisions, readers should seek their own advice and that of their own professional advisers. CFN Media Group, which owns CannabisFN, may be compensated for its Services in the form of cash-based and/or equity- based compensation in the companies it writes about, or a combination of the two. For full disclosure please visit: https://www.cannabisfn.com/legal-disclaimer/.

Copyright © Accelerize Inc. · All Rights Reserved · Privacy Policy · Legal Disclaimer

loading